1. Home
  2. MCB vs SVRA Comparison

MCB vs SVRA Comparison

Compare MCB & SVRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Metropolitan Bank Holding Corp.

MCB

Metropolitan Bank Holding Corp.

HOLD

Current Price

$98.48

Market Cap

1.1B

Sector

Finance

ML Signal

HOLD

Logo Savara Inc.

SVRA

Savara Inc.

HOLD

Current Price

$5.52

Market Cap

1.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MCB
SVRA
Founded
1999
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.1B
1.3B
IPO Year
2017
2009

Fundamental Metrics

Financial Performance
Metric
MCB
SVRA
Price
$98.48
$5.52
Analyst Decision
Buy
Buy
Analyst Count
3
9
Target Price
$98.67
$7.33
AVG Volume (30 Days)
137.7K
2.0M
Earning Date
04-21-2026
05-13-2026
Dividend Yield
1.13%
N/A
EPS Growth
11.64
N/A
EPS
2.92
N/A
Revenue
$11,053,000.00
N/A
Revenue This Year
$37.22
N/A
Revenue Next Year
$14.75
$430.87
P/E Ratio
$34.60
N/A
Revenue Growth
N/A
N/A
52 Week Low
$64.66
$2.26
52 Week High
$102.04
$7.01

Technical Indicators

Market Signals
Indicator
MCB
SVRA
Relative Strength Index (RSI) 54.70 42.96
Support Level $86.38 $5.47
Resistance Level $102.04 $6.15
Average True Range (ATR) 2.49 0.26
MACD -0.16 -0.10
Stochastic Oscillator 49.34 11.11

Price Performance

Historical Comparison
MCB
SVRA

About MCB Metropolitan Bank Holding Corp.

Metropolitan Bank Holding Corp is a bank holding company. It provides a broad range of business, commercial, and retail banking products and services to small businesses, middle-market enterprises, public entities, and individuals in the New York metropolitan area. The services provided by the company include deposits, trade finance, cash management solutions, savings, electronic banking, cards, and others. The company also provides various lending products such as acquisition loans, construction loans, and lines of credit, for retail, office, hospitality, multifamily, mixed-use, warehouse and distribution, and specialty-use properties. The bank derives its revenue in the form of interest income on loans.

About SVRA Savara Inc.

Savara Inc is a clinical-stage biopharmaceutical company. It is focused on rare respiratory diseases. It has one segment specialty pharmaceuticals within the respiratory system. The company's main product candidate, molgramostim, is an inhaled granulocyte-macrophage colony-stimulating factor (GM-CSF) in Phase 3 development for autoimmune pulmonary alveolar proteinosis (aPAP).

Share on Social Networks: